| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 750 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| STOCK FUND SALES | 2011-02 | PURCHASE | 2023-12 | 68,000 | 38,109 | 29,891 | ||||
| UNIT INVESTMENT TRUST SALES | 2022-07 | PURCHASE | 2023-10 | 25,966 | 23,005 | 2,961 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMCAP FUND INC | 66,293 | 87,238 |
| EURO PACIFIC GROWTH | 56,594 | 80,004 |
| GROWTH FUND AMERICA | 67,279 | 87,722 |
| LORD ABBETT SECS TR ALPHA CL C | 112,146 | 92,390 |
| PIONEER FUNDAMENTAL GROWTH | 73,810 | 87,827 |
| PRINCIPAL MID CAP CL C | 1,602 | 1,794 |
| INVESCO OPPENHEIMER DVLP MTS DF CL A | 50,130 | 51,299 |
| PRINCIPAL MID CAP CL A | 57,832 | 81,977 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| FT S&P DIV ARST TGT 25 3Q21 | FMV | ||
| FT S&P TARGET 24 3Q 22 | FMV | ||
| FT S&P DIV ARST TGT 25 4FQ22 | FMV | 150,009 | 185,840 |
| FT S&P DIV ARST TGTG 25 4Q23 | FMV | 20,009 | 21,484 |